About: covid:PMC7453211

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: covid:PMC7453211 Goto Sponge NotDistinct Permalink

An Entity of Type : owl:Thing, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
Creator	Xu, Wei Kim, John Bayley, Andrew Bratman, Scott Chepeha, Douglas Chiu, Kevin Cho, John Giuliani, Meredith Goldstein, David Hope, Andrew Hosni, Ali Huang, Jingyue Irish, Jonathan Monteiro, Eric Ringash, Jolie Spreafico, Anna Waldron, John Witterick, Ian Gilbert, R.W. Hui Huang, Shao O'Sullivan, Brian de Almeida, John
is schema:about of	named entity 'management' named entity 'alternative treatment' named entity 'carcinoma' named entity 'oral cavity' named entity 'N-categories' named entity 'statistically significant' named entity 'OSCC' named entity 'HNSCC' named entity 'OSCC' named entity 'MRI' named entity 'surgical management' named entity 'mucosal' named entity 'tumour control' named entity 'multivariable analysis' named entity 'physical examination' named entity 'retrospective study' named entity 'fractionation' named entity 'ECOG performance status' named entity 'RCT' named entity 'CSS' named entity 'chemotherapy' named entity 'Histological' named entity 'neck dissection' named entity 'randomized controlled trial' named entity 'OSCC' named entity 'metastasis' named entity 'fractionation' named entity 'OSCC' named entity '5-Fu' named entity 'metastasis' named entity 'IMRT' named entity 'AJCC' named entity 'endoscopic' named entity 'IMRT' named entity 'head and neck squamous cell carcinoma' named entity 'fractionation' named entity 'OSCC' named entity 'statistically significant' named entity 'head and neck' named entity 'surgical resection' named entity 'primary tumor' named entity 'tumor' named entity 'Salvage surgery' named entity 'oropharyngeal' named entity 'OSCC' named entity 'high dose' named entity 'chemotherapy' named entity 'insurance' named entity 'clinical trials' named entity 'RCT' named entity 'HNSCC' named entity 'OSCC' named entity 'tumor' named entity 'regulatory approval' named entity 'CTVs' named entity 'fractionation' named entity 'alternative treatment' named entity 'OSCC' named entity 'chemotherapy' named entity 'fractionation' named entity 'clinical history' named entity 'fractionation' named entity 'tumor' named entity 'OSCC' named entity 'phase III' named entity 'HNSCC' named entity 'panitumumab' named entity 'chemotherapy' named entity 'resectable' named entity 'excisional biopsy' named entity 'physical examination' named entity 'fractionation' named entity 'OSCC' named entity 'T4a' named entity 'treatment modality' named entity 'targeted therapy' named entity 'OSCC' named entity 'primary tumor'

Attributes

Values

Creator

Xu, Wei
Kim, John
Bayley, Andrew
Bratman, Scott
Chepeha, Douglas
Chiu, Kevin
Cho, John
Giuliani, Meredith
Goldstein, David
Hope, Andrew
Hosni, Ali
Huang, Jingyue
Irish, Jonathan
Monteiro, Eric
Ringash, Jolie
Spreafico, Anna
Waldron, John
Witterick, Ian
Gilbert, R.W.
Hui Huang, Shao
O'Sullivan, Brian
de Almeida, John

is schema:about of

named entity 'management'
named entity 'alternative treatment'
named entity 'carcinoma'
named entity 'oral cavity'
named entity 'N-categories'
named entity 'statistically significant'
named entity 'OSCC'
named entity 'HNSCC'
named entity 'OSCC'
named entity 'MRI'
named entity 'surgical management'
named entity 'mucosal'
named entity 'tumour control'
named entity 'multivariable analysis'
named entity 'physical examination'
named entity 'retrospective study'
named entity 'fractionation'
named entity 'ECOG performance status'
named entity 'RCT'
named entity 'CSS'
named entity 'chemotherapy'
named entity 'Histological'
named entity 'neck dissection'
named entity 'randomized controlled trial'
named entity 'OSCC'
named entity 'metastasis'
named entity 'fractionation'
named entity 'OSCC'
named entity '5-Fu'
named entity 'metastasis'
named entity 'IMRT'
named entity 'AJCC'
named entity 'endoscopic'
named entity 'IMRT'
named entity 'head and neck squamous cell carcinoma'
named entity 'fractionation'
named entity 'OSCC'
named entity 'statistically significant'
named entity 'head and neck'
named entity 'surgical resection'
named entity 'primary tumor'
named entity 'tumor'
named entity 'Salvage surgery'
named entity 'oropharyngeal'
named entity 'OSCC'
named entity 'high dose'
named entity 'chemotherapy'
named entity 'insurance'
named entity 'clinical trials'
named entity 'RCT'
named entity 'HNSCC'
named entity 'OSCC'
named entity 'tumor'
named entity 'regulatory approval'
named entity 'CTVs'
named entity 'fractionation'
named entity 'alternative treatment'
named entity 'OSCC'
named entity 'chemotherapy'
named entity 'fractionation'
named entity 'clinical history'
named entity 'fractionation'
named entity 'tumor'
named entity 'OSCC'
named entity 'phase III'
named entity 'HNSCC'
named entity 'panitumumab'
named entity 'chemotherapy'
named entity 'resectable'
named entity 'excisional biopsy'
named entity 'physical examination'
named entity 'fractionation'
named entity 'OSCC'
named entity 'T4a'
named entity 'treatment modality'
named entity 'targeted therapy'
named entity 'OSCC'
named entity 'primary tumor'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software